Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping Reply

被引：4
|
作者：
Deenen, Maarten J. [1 ,2 ]
Cats, Annemieke [1 ]
Severens, Johan L. [3 ]
Beijnen, Jos H. [1 ,4 ]
Schellens, Jan H. M. [1 ,4 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Catharina Hosp, Eindhoven, Netherlands
[3] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[4] Univ Utrecht, Utrecht, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 20期
关键词：
5-FLUOROURACIL TOXICITY; CLINICAL-RELEVANCE; DPYD VARIANTS; METAANALYSIS;
D O I：
10.1200/JCO.2016.67.4374
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2434 / U206
页数：3
相关论文
共 50 条
  • [31] 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer
    Inada, T
    Ogata, Y
    Kubota, T
    Tomikawa, M
    Yamamoto, S
    Andoh, J
    Ozawa, I
    Hishinuma, S
    Shimizu, H
    Kotake, K
    ANTICANCER RESEARCH, 2000, 20 (04) : 2457 - 2462
  • [32] DEPRESSED HEPATIC DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY AND FLUOROURACIL-RELATED TOXICITIES
    STEPHAN, F
    ETIENNE, MC
    WALLAYS, C
    MILANO, G
    CLERGUE, F
    AMERICAN JOURNAL OF MEDICINE, 1995, 99 (06): : 685 - 688
  • [33] Dihydropyrimidine dehydrogenase deficiency: A potential etiology for 5-fluorouracil-induced neurotoxicity
    Risso, ME
    Hasson, NK
    Lum, BL
    PHARMACOTHERAPY, 1997, 17 (04): : 847 - 848
  • [34] Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity
    Amstutz, Ursula
    Froehlich, Tanja K.
    Largiader, Carlo R.
    PHARMACOGENOMICS, 2011, 12 (09) : 1321 - 1336
  • [35] DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) AND CLINICAL-PHARMACOLOGY OF 5-FLUOROURACIL - (REVIEW)
    MILANO, G
    ETIENNE, MC
    ANTICANCER RESEARCH, 1994, 14 (6A) : 2295 - 2297
  • [36] The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil
    Li, Long-Hao
    Dong, Hang
    Zhao, Feng
    Tang, Jie
    Chen, Xin
    Ding, Jing
    Men, Hai-Tao
    Luo, Wu-Xia
    Du, Yang
    Ge, Jun
    Tan, Ben-Xu
    Cao, Dan
    Liu, Ji-Yan
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (07) : 1752 - 1760
  • [37] Lack of interaction between bropirimine and 5-fluorouracil on human dihydropyrimidine dehydrogenase
    Yamazaki, S
    Hayashi, M
    Toth, LN
    Ozawa, N
    XENOBIOTICA, 2001, 31 (01) : 25 - 31
  • [38] Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity
    Wei, XX
    McLeod, HL
    McMurrough, J
    Gonzalez, FJ
    FernandezSalguero, P
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03): : 610 - 615
  • [39] 5-Fluorouracil Neurotoxicity in the Absence of Dihydropyrimidine Dehydrogenase Deficiency Case Report
    Jules, Rebecca
    Thaper, Arushi
    Foster, Ryan
    Ameli, Pouya
    Robinson, Christopher
    Pizzi, Michael
    Babi, Marc-Alain
    Maciel, Carolina B.
    Busl, Katharina M.
    Reddy, Raju
    Roth, William
    NEUROHOSPITALIST, 2022, 12 (02): : 366 - 370
  • [40] Individualizing therapy with 5-fluorouracil related to dihydropyrimidine dehydrogenase: Theory and limits
    Milano, G
    Etienne, MC
    THERAPEUTIC DRUG MONITORING, 1996, 18 (04) : 335 - 340
12345